Literature DB >> 11289714

IQGAP1, a negative regulator of cell-cell adhesion, is upregulated by gene amplification at 15q26 in gastric cancer cell lines HSC39 and 40A.

N Sugimoto1, I Imoto, Y Fukuda, N Kurihara, S Kuroda, A Tanigami, K Kaibuchi, R Kamiyama, J Inazawa.   

Abstract

Our previous comparative genomic hybridization (CGH) study revealed a novel amplified region at 15q26 in two cell lines established from diffuse types of gastric cancer (GC). In this amplified region, FES and IGF1R, known targets on 15q26, were located telomeric to the amplicon in the two cell lines, HSC39 and 40A, suggesting that another tumor-associated gene exists in this region. While screening expressed sequence tags (ESTs) for novel genes in this region, we identified the IQGAP1 amplification. IQGAP1 has been reported to encode a ras GAP-related protein, and its interaction with cadherin and/or beta-catenin induces a dissociation of beta-catenin from the cadherin-catenin complex, one of the mechanisms for cell-cell adhesion. Northern and Western blot analyses revealed that amplification of this gene was accompanied by corresponding increases in mRNA and protein expression. Moreover, immunocytochemical staining showed that overexpressed IQGAP1 accumulated at the membrane, suggesting its colocalization with beta-catenin. Taken together, these findings suggest that IQGAP1 may be one of the target genes in the 15q26 amplicon correlated with a malignant phenotype of gastric cancer cells, such as diffuse and invasive characteristics, through the disruption of E-cadherin-mediated cell-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11289714     DOI: 10.1007/s100380170119

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

Review 1.  IQGAP proteins are integral components of cytoskeletal regulation.

Authors:  Michael W Briggs; David B Sacks
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

2.  Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

Authors:  Cong-Cong Wu; Hao Li; Yao Xiao; Lei-Lei Yang; Lei Chen; Wei-Wei Deng; Lei Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  J Mol Histol       Date:  2018-05-30       Impact factor: 2.611

Review 3.  Cell growth and metastasis in pancreatic cancer: is Vav the Rho'd to activation?

Authors:  Daniel D Billadeau
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Sequestering Rac with PKA confers cAMP control of cytoskeletal remodeling.

Authors:  Jeremy S Logue; Jennifer L Whiting; John D Scott
Journal:  Small GTPases       Date:  2011-05

5.  IQGAP1 plays an important role in the invasiveness of thyroid cancer.

Authors:  Zhi Liu; Dingxie Liu; Ermal Bojdani; Adel K El-Naggar; Vasily Vasko; Mingzhao Xing
Journal:  Clin Cancer Res       Date:  2010-10-19       Impact factor: 12.531

Review 6.  Protein scaffolds in MAP kinase signalling.

Authors:  Matthew D Brown; David B Sacks
Journal:  Cell Signal       Date:  2008-12-03       Impact factor: 4.315

7.  IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors.

Authors:  Katherine L Jameson; Pawel K Mazur; Ashley M Zehnder; Jiajing Zhang; Brian Zarnegar; Julien Sage; Paul A Khavari
Journal:  Nat Med       Date:  2013-04-21       Impact factor: 53.440

Review 8.  Bench to bedside and back again: molecular mechanisms of alpha-catenin function and roles in tumorigenesis.

Authors:  Jacqueline M Benjamin; W James Nelson
Journal:  Semin Cancer Biol       Date:  2007-09-04       Impact factor: 15.707

Review 9.  IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis.

Authors:  Colin D White; Matthew D Brown; David B Sacks
Journal:  FEBS Lett       Date:  2009-05-09       Impact factor: 4.124

10.  Proteomic investigation of human burn wounds by 2D-difference gel electrophoresis and mass spectrometry.

Authors:  Alonda C Pollins; David B Friedman; Lillian B Nanney
Journal:  J Surg Res       Date:  2007-06-29       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.